We are live on ! Find out more
CC

Cannell & Co Portfolio holdings

AUM $3.15B
1-Year Est. Return 30.62%
This Fund
S&P 500
This Quarter Est. Return
-10.13%
1 Year Est. Return
+30.62%
3 Year Est. Return
+51.59%
5 Year Est. Return
+187.25%
10 Year Est. Return
+311.51%
AUM
$3.08B
AUM Growth
-$454M
Cap. Flow
-$10.5M
Cap. Flow %
-0.34%
Top 10 Hldgs %
30.04%
Holding
290
New
20
Increased
70
Reduced
90
Closed
22

Top Sells

Rank Stock Value
1
PARA
Paramount Global Class B
PARA
+$69.9M
2
WHR icon
Whirlpool
WHR
+$51.8M
3
HRB icon
H&R Block
HRB
+$37.9M
4
WPC icon
W.P. Carey
WPC
+$26.3M
5
CELG
Celgene Corp
CELG
+$25.3M

Sector Composition

Rank Sector Weight
1 Healthcare 21.57%
2 Industrials 19.91%
3 Technology 14.58%
4 Financials 10.22%
5 Energy 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VLY icon
226
Valley National Bancorp
VLY
$8.28B
$344K 0.01%
35,000
ESLT icon
227
Elbit Systems
ESLT
$34.7B
$336K 0.01%
4,500
NEM icon
228
Newmont
NEM
$95.8B
$326K 0.01%
20,270
-450
-2% -$8.06K
PCYO icon
229
Pure Cycle
PCYO
$258M
$318K 0.01%
64,000
HES
230
DELISTED
Hess
HES
$313K 0.01%
6,258
DL
231
DELISTED
China Distance Education Holdings Limited
DL
$298K 0.01%
23,279
FMI
232
DELISTED
Foundation Medicine, Inc.
FMI
$294K 0.01%
+15,910
New +$397K
DUK icon
233
Duke Energy
DUK
$97.5B
$291K 0.01%
4,048
-75
-2% -$5.43K
PAA icon
234
Plains All American Pipeline
PAA
$16.8B
$287K 0.01%
9,441
-200
-2% -$7.31K
MJN
235
DELISTED
Mead Johnson Nutrition Company
MJN
$285K 0.01%
4,042
-125
-3% -$10.3K
ORBC
236
DELISTED
ORBCOMM, Inc.
ORBC
$279K 0.01%
50,000
TROW icon
237
T. Rowe Price
TROW
$25.1B
$278K 0.01%
4,000
DD
238
DELISTED
Du Pont De Nemours E I
DD
$272K 0.01%
5,648
-299
-5% -$16K
HAL icon
239
Halliburton
HAL
$29.4B
$268K 0.01%
7,580
+800
+12% +$31.5K
FRME icon
240
First Merchants
FRME
$2.81B
$262K 0.01%
10,006
INTU icon
241
Intuit
INTU
$79.6B
$257K 0.01%
2,892
AES.PRC.CL
242
DELISTED
AES Corporation Class C Preferred
AES.PRC.CL
$248K 0.01%
+5,000
New +$252K
JNS
243
DELISTED
Janus Capital Group Inc
JNS
$245K 0.01%
17,999
XYL icon
244
Xylem
XYL
$29.2B
$238K 0.01%
7,240
VRTX icon
245
Vertex Pharmaceuticals
VRTX
$123B
$228K 0.01%
2,188
-150
-6% -$19.3K
AMLP icon
246
Alerian MLP ETF
AMLP
$12.7B
$225K 0.01%
+3,600
New +$262K
NSH
247
DELISTED
NuStar GP Holdings LLC
NSH
$219K 0.01%
8,200
BPL
248
DELISTED
Buckeye Partners, L.P.
BPL
$217K 0.01%
3,658
RTN
249
DELISTED
Raytheon Company
RTN
$216K 0.01%
+1,979
New +$207K
BUD icon
250
AB InBev
BUD
$156B
$213K 0.01%
2,000

Similar funds

Cannell & Co's Q3 2015 Portfolio in Review

As of Q3 2015, Cannell & Co held 290 positions worth $3.08B, down 13% from $3.53B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Cannell & Co's Q3 2015 filing shows 20 new, 70 increased, 90 reduced and 22 closed positions. Its largest new stake was Vistance Networks Inc: 2,112,135 shares worth $63.4M. The largest sale was Paramount Global Class B, an estimated $69.9M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Industrials and Technology.

  • Cannell & Co's largest Q3 2015 buy was Vistance Networks Inc: 2,112,135 shares worth $63.4M.
  • Cannell & Co added most to WisdomTree in Q3 2015, an estimated $46M increase.
  • Cannell & Co's biggest Q3 2015 reduction was Paramount Global Class B, cutting an estimated $69.9M.
  • Cannell & Co fully exited Intercept Pharmaceuticals, Inc. in Q3 2015, selling an estimated $13.6M.
  • Cannell & Co's ten largest holdings make up 30% of its $3.08B portfolio in Q3 2015.
  • Cannell & Co opened 20 new positions and closed 22 in Q3 2015.
  • Cannell & Co's portfolio value fell 13% quarter-over-quarter to $3.08B.

Based on Cannell & Co's 13F filing for Q3 2015, filed 13 Nov 2015.